
Deborah Toppmeyer, MD
Advertisement
Articles by Deborah Toppmeyer, MD


ACR Appropriateness Criteria® Ductal Carcinoma in Situ
BySeth A. Kaufman, MD,Eleanor E. R. Harris, MD,Lisa Bailey, MD,Manjeet Chadha, MD,Sharon C. Dutton, MD,Gary M. Freedman, MD,Sharad Goyal, MD,Michele Y. Halyard, MD,Kathleen C. Horst, MD,Kristina L. M. Novick, MD,Catherine C. Park, MD,W. Warren Suh, MD,Deborah Toppmeyer, MD,Jennifer Zook, MD,Bruce G. Haffty, MD
Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.

Management recommendations for breast cancer local-regional recurrence (LRR), including patient scenarios, are reviewed, and represent evidence-based data and expert opinion of the American College of Radiology Appropriateness Criteria Expert Panel on LRR.
Advertisement
Latest Updated Articles
ACR Appropriateness Criteria® Ductal Carcinoma in SituJune 15th 2015
Advertisement
Advertisement
Trending on CancerNetwork
1
Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC
2
FDA Approves Adjuvant Belzutifan/Pembrolizumab in Clear Cell RCC Post Nephrectomy
3
Capivasertib Combo Earns FDA Approval in PTEN-Deficient Metastatic HSPC
4
Quadruplet Combo Appears Effective in High-Risk Smoldering Multiple Myeloma
5